Akso Health Group operates a social e-commerce mobile platform in China. The company operates Xiaobai Maimai App, which offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, etc. It also offers consultancy and information technology support services; and trades in branded products, as well as promotes products. The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021. Akso Health Group was founded in 2014 and is headquartered in Beijing, China. As of July 13, 2021, Akso Health Group operates as a subsidiary of Webao Limited.
IPO Year: 2017
Exchange: NASDAQ
Website: https://www.xiaobaimaimai.com
QINGDAO, China, Feb. 18, 2025 /PRNewswire/ -- Akso Health Group (NASDAQ:AHG) (hereinafter referred to as "Akso Health," "the Company," or "we") announced today its integration of DeepSeek's advanced artificial intelligence technology. This initiative aims to further enhance AI-powered medical consultation, optimize healthcare resource allocation, and provide users with more precise and efficient medical services. The utilization of DeepSeek not only represents a significant breakthrough in the field of AI-driven healthcare but also sets a new benchmark for the industry's intelligent transformation. As an innovative medical technology company, AHG leverages DeepSeek's multimodal large-scale
QINGDAO CHINA, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Akso Health Group (NASDAQ:AHG) ( "Akso Health," "the Company," or "we") today announced its plan to make an equity investment in Deyihui, an online clinic based in China. Akso Health plans to tap into the online clinic business initially in China and if the results are satisfactory, to expand this business to the other countries and regions. Given the rapid growth of virtual consultations in mainland China, management believes this is a significant untapped market where the Company may leverage its capital resources as well as first-move advantage. The planned equity investment in Deyuhui is expected to aid management in getting famili
BEIJING, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Akso Health Group (NASDAQ:AHG) ("Akso Health" the "Company" or "we"), announced today that on October 11, 2023, it received a letter from the Nasdaq Listing Qualifications Department notifying the Company that it had regained compliance with the minimum bid price requirement. On October 26, 2022, the Company received a notification that it's American Depositary Shares ("ADS") failed to maintain a minimum bid price of $1.00 over the previous 30 consecutive business days, as required by Nasdaq Listing Rules of The Nasdaq Stock Market. The closing bid price of the Company's ADS was at $1.00 per share or greater from September 15, 2023 to October 10,
BEIJING, April 27, 2023 (GLOBE NEWSWIRE) -- Akso Health Group (NASDAQ:AHG) ("Akso Health" the "Company" or "we"), today announced that the Company has received a notification letter from the Nasdaq Stock Market LLC ("Nasdaq") on April 25, 2023, notifying the Company that it has been granted an additional 180-day compliance period, or until October 23, 2023 to regain compliance with Nasdaq's minimum bid price rule. Nasdaq's determination is based on the Company meeting the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on the Capital Market with the exception of the bid price requirement, and the Company's
BEIJING, March 06, 2023 (GLOBE NEWSWIRE) -- Akso Health Group (NASDAQ:AHG) ("Akso Health" the "Company" or "we"), today announced that on February 28, 2023, the Company received a notification letter from the Nasdaq Listing Qualifications Staff of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it is no longer in compliance with the minimum stockholders' equity requirement for continued listing on the Nasdaq Global Market set forth in Nasdaq Listing Rule 5450(b)(1)(A) (the "Nasdaq Listing Rules"). The Nasdaq Listing Rules requires listed companies to maintain stockholders' equity of at least $10 million. The Company's Form 6-K filed with the Securities and Exchange Commis
BEIJING, Oct. 28, 2022 /PRNewswire/ -- Akso Health Group (NASDAQ:AHG) ("Akso Health" the "Company" or "we"), today announced that the Company has received a written notification (the "Notification Letter") from the Nasdaq Stock Market LLC ("Nasdaq") on October 26, 2022, notifying the Company that it is not in compliance with the minimum bid price requirement set forth in Nasdaq Rules for continued listing on the Nasdaq. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of US$1.00 per share, and Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a period of 30 consecutive b
BEIJING, Aug. 17, 2022 /PRNewswire/ -- Akso Health Group. (NASDAQ:AHG) ("Akso Health" the "Company" or "we"), today announced that the Company received a written notification (the "Notification") from the Nasdaq Stock Market LLC ("Nasdaq") on August 16, 2022, indicating the Company is not in compliance with the timely filing requirement for continued listing under Nasdaq Listing Rules 5250(c)(1) since the Company has not yet filed its Annual Report on Form 20-F for the fiscal year ended March 31, 2022 (the "Filing") with the Securities and Exchange Commission (the "SEC"). In accordance with Nasdaq Listing Rule 5250(c)(1), the Company has up to 60 calendar days to either cure the deficiency o
F-3/A - Akso Health Group (0001702318) (Filer)
6-K - Akso Health Group (0001702318) (Filer)
6-K - Akso Health Group (0001702318) (Filer)
F-3/A - Akso Health Group (0001702318) (Filer)
F-3/A - Akso Health Group (0001702318) (Filer)
RW - Akso Health Group (0001702318) (Filer)
F-3/A - Akso Health Group (0001702318) (Filer)
6-K - Akso Health Group (0001702318) (Filer)
20-F - Akso Health Group (0001702318) (Filer)
F-6 POS - Akso Health Group (0001702318) (Subject)